Qué es, cómo funciona y tipos de quimioterapia

Bibliografía

1. www.rae.es
2. www.wikipedia.org
3. Picó C. Bases farmacológicas del tratamiento antineoplásico. En: Cortés Funes H, Colomer Bosch, R. Principios del tratamiento oncológico. Publicaciones Permanyer. ISBN: 978-84-92620-17-3. Barcelona, 2009, p. 201-218.
4. DeVita VT. Principles of chemotherapy. En: DeVita VT, Hellman S, Rosemberg SA. Cancer Principles and Practice of Oncology. Filadelfia: Lippincott;1982. p. 132-55.
5. Rosell R, Monzó M, Alberola V. Determinants of response and resistance to cytotoxics. Semin Oncol 2002;29(1 Suppl 4):110-8.
6. Citron ML, Berry DA, Cirrincione C, et al. Randomized trial of dose-dense vs. Conventionally scheduled and sequential vs. concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 2003;21(8):1431-9.
7. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307(5706):58-62.
8. García Mata J, García-Palomo Pérez A, García Gómez J. Quimioterapia antineoplásica. En: Principios del tratamiento oncológico. Cortés Funes H, Colomer Bosch, R. Publicaciones Permanyer. ISBN: 978-84-92620-17-3. Barcelona, 2009, p. 219-259.
9. Guillén Ponce C, Molina Garrido MJ, Carrato Mena A. Cisplatino y análogos. En: Oncomecum 2013. E. Díaz-Rubio, P. Pérez Segura, Publicaciones Permanyer, Barcelona, 2013, p. 25-38.
10. Rivera F, Grávalos C, García-Carbonero R; SEOM (Spanish Society of Clinical Oncology). SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma. Clin Transl Oncol. 2012;14(7):528-35.
11. Cassidy J, Saltz L, Twelves C, Van Cutsem E, Hoff P, Kang Y, Saini JP, Gilberg F, Cunningham D. Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients. Ann Oncol 2011;22(12):2604-9.
12. Provencio M, Sánchez A, Artal A, Sánchez Torres JM, de Castro J, Dómine M, Viñolas N, Sánchez A, Pérez FJ. Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary. Clin Transl Oncol. 2013;15(8):659-64. doi: 10.1007/s12094-012-0989-6.
13. Bojko P, Schimmel G, Bosse D, Abenhardt W. Metronomic oral cyclophosphamide in patients with advanced solid tumors. Onkologie. 2012;35(1-2):35-8.
14. Azuma H, Sakamoto T, Kiyama S, Ubai T, Kotake Y, Inamoto T, Takahara K, Nishimura Y, Segawa N, Katsuoka Y. Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer. Am J Clin Oncol 2008;31(2):188-94.

5/5